Podiatrist, Foot & Ankle Surgery · Brooklyn, NY
NPI
1497239792
Since 2018
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
596 Pennsylvania Ave
Brooklyn, NY, 11207
Phone (347) 442-5847
Groups this clinician bills Medicare through
Medicare paid, 2024
$271K
680 services
Medicare patients, 2024
103
Average age 74
Drug cost, 2024
$944K
3,858 prescriptions
Company payments, 2025
$727
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Junior R King was code 11721 (nail procedure), 130 times for 83 patients. In total Junior R King billed 680 services in 26 codes, and Medicare paid $271K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 11721 Nail Procedure | Office | 130 | 83 | $35.18 | $4,573 |
| 11056 Removal or Shaving of Skin Growth | Office | 102 | 75 | $75.33 | $7,683 |
| 99213 Office E&M - Established | Office | 82 | 53 | $82.28 | $6,747 |
| 99214 Office E&M - Established | Office | 30 | 26 | $105.98 | $3,180 |
| 11057 Removal or Shaving of Skin Growth | Office | 26 | 20 | $81.54 | $2,120 |
By year: 2022 $50K for 730 services; 2023 $35K for 1,572 services; 2024 $271K for 680 services.
Medicare prescription drug claims, 2024
In 2024, the drug Junior R King prescribed most often to Medicare patients was Doxepin Hcl, with 596 prescriptions and refills. In total Junior R King wrote 3,858 Medicare prescriptions that cost $944K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxepin Hcl Generic | 596 | 610 | 152 | $179K |
| Fluocinonide Generic | 307 | 313 | 54 | $37K |
| Ammonium Lactate Generic | 289 | 330 | 162 | $5,299 |
| Diclofenac Sodium Generic | 251 | 264 | 161 | $26K |
| Clobetasol Propionate Generic | 251 | 358 | 76 | $134K |
| Ketoconazole Generic | 239 | 269 | 118 | $12K |
| Diclofenac Sodium Er Diclofenac Sodium | 169 | 169 | 18 | $13K |
| Clotrimazole Generic | 141 | 141 | 39 | $7,931 |
| Caspofungin Acetate Generic | 135 | 135 | 63 | $33K |
| Ciclopirox Generic | 116 | 116 | 64 | $3,901 |
| Econazole Nitrate Generic | 116 | 127 | 76 | $4,705 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 91 | 95 | 38 | $21K |
| Gabapentin Generic | 86 | 90 | 50 | $1,256 |
| Budesonide Er Budesonide | 74 | 74 | 27 | $69K |
| Diflorasone Diacetate Generic | 67 | 72 | 20 | $45K |
Brand drugs: 321 claims; generic drugs: 3,486 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Junior R King $727 ($727 in general payments such as food, travel and fees) from 7 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $246.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.